番茄视频

Investigational intravesical solution led to complete response rate of 79%

And our roundtable of experts discuss selinexor for wild-type p53 disease

Algorithm proved accurate where traditional risk models have failed, but needs more testing

Tool could identify nonsmokers most likely to benefit from low-dose CT screening

Applies to all approved therapies, but benefits still outweigh risks, agency says

The strategy was effective for patients who were due or overdue for screening

Nirogacestat reduced the risk of disease progression or death by 71% in randomized trial

Study validates concerns about benign prostatic hyperplasia-related PSMA-PET false positives

Adding atezolizumab to FLOT led to more downstaging, complete regressions versus chemo alone

Researchers suggest the drug is a promising option for this rare subgroup

Viral campaign will erase some $60 million in medical debt

Health news and commentary from around the Web gathered by 番茄视频 staff

Worse PFS associated with circulating tumor DNA detected as early as end of treatment

However, it may benefit children at increased risk of thrombosis